ONKOVISION® TUMORSTENT - Urovision-Urotech
4.8 (328) In stock
Optimal management of recurrent and metastatic upper tract
The classification of the bladder cancer based on Vision
ONKOVISION® TUMORSTENT - Urovision-Urotech
EIT Health 2018 HeadStart Winner Inovus Medical announces launch
The Evolving Therapeutic Landscape and Role of Enfortumab Vedotin
The classification of the bladder cancer based on Vision
抗压输尿管支架套装（内置金属）
ASCO GU 2024: Interim Analysis of a Phase I/Ib Study of Enfortumab
Xpert Bladder Cancer Monitor for Bladder Cancer Surveillance
抗压输尿管支架套装（内置金属）
))/3491260.json)
